Literature DB >> 28508724

The impact of simulated motion blur on lesion detection performance in full-field digital mammography.

Ahmed K Abdullah1,2, Judith Kelly3, John D Thompson2, Claire E Mercer2, Rob Aspin4, Peter Hogg2,5.   

Abstract

OBJECTIVE: Motion blur is a known phenomenon in full-field digital mammography, but the impact on lesion detection is unknown. This is the first study to investigate detection performance with varying magnitudes of simulated motion blur.
METHODS: 7 observers (15 ± 5 years' reporting experience) evaluated 248 cases (62 containing malignant masses, 62 containing malignant microcalcifications and 124 normal cases) for 3 conditions: no blurring (0 mm) and 2 magnitudes of simulated blurring (0.7 and 1.5 mm). Abnormal cases were biopsy proven. Mathematical simulation was used to provide a pixel shift in order to simulate motion blur. A free-response observer study was conducted to compare lesion detection performance for the three conditions. The equally weighted jackknife alternative free-response receiver operating characteristic was used as the figure of merit. Test alpha was set at 0.05 to control probability of Type I error.
RESULTS: The equally weighted jackknife alternative free-response receiver operating characteristic analysis found a statistically significant difference in lesion detection performance for both masses [F(2,22) = 6.01, p = 0.0084] and microcalcifications [F(2,49) = 23.14, p < 0.0001]. The figures of merit reduced as the magnitude of simulated blurring increased. Statistical differences were found between some of the pairs investigated for the detection of masses (0.0 vs 0.7 and 0.0 vs 1.5 mm) and all pairs for microcalcifications (0.0 vs 0.7, 0.0 vs 1.5 and 0.7 vs 1.5 mm). No difference was detected between 0.7 and 1.5 mm for masses.
CONCLUSION: The mathematical simulation of motion blur caused a statistically significant reduction in lesion detection performance. These false-negative decisions could have implications for clinical practice. Advances in knowledge: This research demonstrates for the first time that motion blur has a negative and statistically significant impact on lesion detection performance in digital mammography.

Mesh:

Year:  2017        PMID: 28508724      PMCID: PMC5594981          DOI: 10.1259/bjr.20160871

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Sample size tables for receiver operating characteristic studies.

Authors:  N A Obuchowski
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

2.  Observer studies involving detection and localization: modeling, analysis, and validation.

Authors:  Dev P Chakraborty; Kevin S Berbaum
Journal:  Med Phys       Date:  2004-08       Impact factor: 4.071

3.  Analysis of motion during the breast clamping phase of mammography.

Authors:  Wang Kei Ma; Mark F McEntee; Claire Mercer; Judith Kelly; Sara Millington; Peter Hogg
Journal:  Br J Radiol       Date:  2016-01-07       Impact factor: 3.039

4.  ROCView: prototype software for data collection in jackknife alternative free-response receiver operating characteristic analysis.

Authors:  J Thompson; P Hogg; S Thompson; D Manning; K Szczepura
Journal:  Br J Radiol       Date:  2012-05-09       Impact factor: 3.039

5.  Does subcutaneous adipose tissue behave as an (anti-)thixotropic material?

Authors:  Marion Geerligs; Gerrit W M Peters; Paul A J Ackermans; Cees W J Oomens; Frank P T Baaijens
Journal:  J Biomech       Date:  2010-02-19       Impact factor: 2.712

6.  Correlation of free-response and receiver-operating-characteristic area-under-the-curve estimates: results from independently conducted FROC∕ROC studies in mammography.

Authors:  Federica Zanca; Stephen L Hillis; Filip Claus; Chantal Van Ongeval; Valerie Celis; Veerle Provoost; Hong-Jun Yoon; Hilde Bosmans
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

Review 7.  Impact of full field digital mammography on the classification and mammographic characteristics of interval breast cancers.

Authors:  Mark Knox; Angela O'Brien; Endre Szabó; Clare S Smith; Helen M Fenlon; Michelle M McNicholas; Fidelma L Flanagan
Journal:  Eur J Radiol       Date:  2015-03-14       Impact factor: 3.528

Review 8.  New developments in observer performance methodology in medical imaging.

Authors:  Dev P Chakraborty
Journal:  Semin Nucl Med       Date:  2011-11       Impact factor: 4.446

9.  Malignant lesions initially subjected to short-term mammographic follow-up.

Authors:  Eric L Rosen; Jay A Baker; Mary Scott Soo
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

10.  Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program.

Authors:  Niamh M Hambly; Michelle M McNicholas; Niall Phelan; Gormlaith C Hargaden; Ann O'Doherty; Fidelma L Flanagan
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

View more
  3 in total

1.  How does image quality affect radiologists' perceived ability for image interpretation and lesion detection in digital mammography?

Authors:  Joana Boita; Ruben E van Engen; Alistair Mackenzie; Anders Tingberg; Hilde Bosmans; Anetta Bolejko; Sophia Zackrisson; Matthew G Wallis; Debra M Ikeda; Chantal Van Ongeval; Ruud Pijnappel; Mireille Broeders; Ioannis Sechopoulos
Journal:  Eur Radiol       Date:  2021-01-21       Impact factor: 5.315

2.  Differences between human and machine perception in medical diagnosis.

Authors:  Taro Makino; Stanisław Jastrzębski; Witold Oleszkiewicz; Celin Chacko; Robin Ehrenpreis; Naziya Samreen; Chloe Chhor; Eric Kim; Jiyon Lee; Kristine Pysarenko; Beatriu Reig; Hildegard Toth; Divya Awal; Linda Du; Alice Kim; James Park; Daniel K Sodickson; Laura Heacock; Linda Moy; Kyunghyun Cho; Krzysztof J Geras
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

Review 3.  Errors in Mammography Cannot be Solved Through Technology Alone

Authors:  Ernest Usang Ekpo; Maram Alakhras; Patrick Brennan
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.